ImmunityBio Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. D.Boral Maintained a Buy Rating on the Stock.
ImmunityBio Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. D.Boral Maintained a Buy Rating on the Stock.
ImmunityBio股價上漲，公司公佈了超出預期的Q3財務業績。D.Boral維持對該股的買入評級。
ImmunityBio Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. D.Boral Maintained a Buy Rating on the Stock.
ImmunityBio股價上漲，公司公佈了超出預期的Q3財務業績。D.Boral維持對該股的買入評級。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間